Purpose: Frontal plane lower limb alignment has important associations with the distribution of load in the femorotibial joint and with the location and magnitude of structural progression of knee osteoarthritis (OA). Alignment is conventionally determined as the mechanical axis (or hip-knee-ankle [HKA]) angle from full limb radiographs. Yet, other, simpler measures of frontal plane alignment exist, including a new method for measuring the anatomical axis (or femorotibial angle [FTA]) from fixed flexion radiographs, aligned with measures of radiographic joint space. However, it is unclear how this measure, or non-radiographic goniometry, predict cartilage thickness loss as measured quantitatively with MRI in relation to HKA. The objective of the current study was hence to identify how this new FTA measure and goniometry predict medial and lateral cartilage thickness loss from MRI compared with the HKA gold standard. Methods: Participants were selected from the Osteoarthritis Initiative (OAI). 450 knees were available with baseline and 1-year follow-up MRI measurements (coronal FLASH acquisitions) and 489 with baseline and 2-year follow-up MRI (sagittal DESS). Knees with incomplete measures of frontal plane alignment or with Kellgren and Lawrence grade <2 (no definite radiographic OA) were excluded. Progression was defined as cartilage thickness loss exceeding the smallest detectable change (SDC) in the medial (MFTC: -102mm [FLASH], -111mm [DESS]) or lateral femorotibial compartment (LFTC: -92mm [FLASH], -121mm [DESS]), respectively. HKA, FTA and goniometer measures were categorized into (a) neutral, (b) varus and (c) valgus. Neutral HKA and goniometer angles were defined as -2 to 2 .
Purpose: Frontal plane lower limb alignment has important associations with the distribution of load in the femorotibial joint and with the location and magnitude of structural progression of knee osteoarthritis (OA). Alignment is conventionally determined as the mechanical axis (or hip-knee-ankle [HKA]) angle from full limb radiographs. Yet, other, simpler measures of frontal plane alignment exist, including a new method for measuring the anatomical axis (or femorotibial angle [FTA]) from fixed flexion radiographs, aligned with measures of radiographic joint space. However, it is unclear how this measure, or non-radiographic goniometry, predict cartilage thickness loss as measured quantitatively with MRI in relation to HKA. The objective of the current study was hence to identify how this new FTA measure and goniometry predict medial and lateral cartilage thickness loss from MRI compared with the HKA gold standard. Methods: Participants were selected from the Osteoarthritis Initiative (OAI). 450 knees were available with baseline and 1-year follow-up MRI measurements (coronal FLASH acquisitions) and 489 with baseline and 2-year follow-up MRI (sagittal DESS Based on a previously determined offset across all OAI participants with FTA and HKA measurements, a neutral FTA was defined as -6.3 to -2.3 . Correlations between cartilage loss and alignment measures were determined by calculating Pearson coefficients. Logistic regression models were used to determine the odds of medial and lateral progression in varus and valgus knees, measured by each alignment method, and using neutral knees as a reference. All models were adjusted for age, sex and body mass index. Results: Correlations of MFTC/LFTC cartilage thickness loss between baseline and 1-year follow-up were largest for HKA (r¼0.21/-0.19) and somewhat lower for FTA (r¼0.15/-0.13) and goniometry (r¼0.12/-0.11). Correlations of cartilage loss between baseline and 2-year follow-up were similar for HKA (r¼0.28/-0.29) and FTA (r¼0.28/-0.30) and lower for goniometry (r¼0.11/-0.16). When applying the 4.3 valgus offset to the 1-year follow-up cohort, the new FTA alignment measure predicted MFTC progression (adjOR¼3.05) and LFTC progression (adjOR¼2.67) as well as the HKA gold standard (adjOR¼3.17 and 2.31, respectively, Table 1 ). Without using the offset, the prediction by the new measurement was less strong. In the 2-year follow-up cohort, FTA appeared to be a better predictor for MFTC progression (adjOR¼2.44) and LFTC progression (adjOR¼3.40) than the HKA gold standard (adjOR ¼ 1.66 and 2.24, respectively, Figure 1 ). Without using the FTA offset, the new measurement was a good predictor of MFTC progression (adjOR¼4.09), but not LFTC progression. Goniometry was a weak predictor for MFTC and LFTC progression in both cohorts (Table 1; Figure 1 ). Conclusions: Compared to the gold standard of measuring mechanical alignment using full limb radiographs (HKA), the new FTA measurement was at least as good in predicting MFTC/LFTC cartilage thickness loss when Table 1 Correlation matrix of KOOS and MRI variables.
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KOOS_Pain -.270** (p¼0.008) -.167 ( accounting for the systematic offset between both methods. Goniometry, in contrast, was a poor predictor for medial and lateral cartilage thickness loss. If the FTA offset is not adjusted for, the new method of measuring alignment from fixed flexion radiographs is shifted in the varus direction, and has limited ability to predict future LFTC cartilage loss. Purpose: With recent focus on the potentially treatable inflammatory component of osteoarthritis (OA), there has been increased interest in the detection and implications of a joint effusion as a marker of inflammation. Effusions can be detected clinically, primarily via tap and bulge signs on physical examination. However, there has been surprisingly little objective evaluation of these clinical signs, perhaps because presence of an effusion at imaging is also somewhat subjective. Using clinical and imaging data from the Osteoarthritis Initiative, we sought to determine (1) sensitivity and specificity of the tap and bulge signs for the presence of a joint effusion on MRI as measured by two semi-quantitative scoring systems, and (2) the clinical implication of an effusion detected on physical examination in terms of pain and disability at presentation and the rate of use of intra-articular steroid injection over the next year. Methods: Patients: This retrospective cohort study includes knees from 40 subjects from the Osteoarthritis Initiative (OAI) that went on to have a knee steroid injection within 1 year of baseline evaluation, and 40 that did not, matched by age, sex, and Kellgren-Lawrence (K-L) grade of radiographic OA. Age averaged 62.3 years (range: 45-78), K-L grade 2.8±1.0 (mean±standard deviation), 78% were women, and body mass index (BMI) averaged 30.3±4.6. Clinical data: In addition to demographics above, the variables extracted from OAI included at baseline visit (year 0) the tap and bulge signs for effusion (positive/negative), Western Ontario & McMaster (WOMAC) pain and status scores. MRI evaluation for effusion: After initial consensus training, two musculoskeletal radiologists separately scored each knee on two semiquantitative effusion scores: MOAKS, which grades the whole joint by a single number from 0 (no effusion) to 3 (large effusion), and KIMRISS, where the depth of joint fluid is measured and graded at four sites on axial and sagittal MRI (medial, lateral and superior suprapatellar recesses and Baker cyst), then summed for a score from 0-12. Statistics: The tap sign was highly insensitive (only four positive cases) and not examined further. We compared the prevalence and size of effusions at MRI in patients with positive and negative bulge sign using nonparametric Mann-Whitney U test. We computed sensitivity/specificity of the bulge sign for detecting an effusion visible at MRI at various MOAKS and KIMRISS thresholds. In bulgeþ and bulge-cohorts we compared WOMAC pain and status scores at baseline and the rates of steroid injections in that knee after 1 year, all by Mann-Whitney U test. Results: Effusion prevalence was high at MRI (MOAKS >¼1 in 70%, KIMRISS >¼4 in 72%). The bulge-positive knees (n¼18) had significantly larger effusions than bulge-negative knees (n¼62), whether by MOAKS (1.3±0.1 vs. 0.8±0.1, p¼0.01) or KIMRISS (5.6±0.3 vs. 4.2±0.3, p¼0.02; Figure 1 ). In the full data set, sensitivity for an effusion was optimal at thresholds of MOAKS 1 or KIMRISS 4, at 0.3-0.32, with specificity 0.83-1.0, and there was no significant difference in WOMAC pain or status scores between bulgeþ/bulge-¼ knees. However, when analysis was limited to non-obese patients (BMI<30, n¼36), sensitivity improved slightly, to 0.38-0.39, and the bulgeþ knees (n¼9) had substantially higher average WOMAC scores than others (pain 5.1 vs 2.1, p¼0.003, status 23.8 vs 10.0, p¼0.004). Within the year after initial observation, 14/18 (77%) of the bulgeþ group had received steroid injections in that knee, vs. 26/62 (42%) of the bulge-group (p¼0.007).
Conclusions: Signs of knee effusion on physical examination are insensitive, especially in obese patients, and the tap sign is so rarely positive as to be of little value. When an effusion is detected by bulge sign in a patient with established knee OA, it is associated with a larger knee effusion at MRI, significantly greater current pain and disability, and a significantly higher rate of steroid injections into that knee in the next year than if no effusion is detected clinically. These associations support the notion that a joint effusion reflects active synovitis, and encourage careful clinical examination for knee effusions. 
